IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 155 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $651,000 | +14.6% | 25,000 | +44.9% | 0.30% | +5.7% |
| Q3 2020 | $568,000 | -74.3% | 17,250 | -78.4% | 0.28% | -79.1% |
| Q4 2019 | $2,214,000 | -19.7% | 80,000 | -47.2% | 1.34% | -22.9% |
| Q3 2019 | $2,757,000 | -39.7% | 151,500 | -18.8% | 1.74% | -47.6% |
| Q2 2019 | $4,573,000 | +157.8% | 186,500 | 0.0% | 3.32% | +100.1% |
| Q1 2019 | $1,774,000 | +7.5% | 186,500 | 0.0% | 1.66% | +6.2% |
| Q4 2018 | $1,651,000 | -26.6% | 186,500 | -6.8% | 1.56% | +16.8% |
| Q3 2018 | $2,250,000 | – | 200,000 | – | 1.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |